Challenges associated with controlled psychopharmacological research trials in adolescents with eating disorders
- PMID: 18392169
- PMCID: PMC2247458
Challenges associated with controlled psychopharmacological research trials in adolescents with eating disorders
Abstract
Introduction: Eating disordered populations present many unique challenges both to clinicians and researchers. Adolescents with eating disorders can be difficult to treat, and the challenges associated with research in this area can be significant.
Objectives: This paper was written with three main objectives in mind: to comment on some of the barriers impeding mental health research in general, to highlight challenges faced in the design and implementation of ED-specific studies, and to integrate personal insight into some of the many challenges that we have encountered during our experience with a randomized clinical trial examining the efficacy of olanzapine for the adjunctive treatment of youth with Anorexia Nervosa.
Discussion: It is hoped that providing information in this context will allow researchers greater insight into some of the many challenges that accompany study of this cohort.
Introduction: Les adolescents souffrant de troubles du comportement alimentaire présentent des défis uniques aux cliniciens et aux chercheurs. Ces adolescents sont difficiles à traiter et la recherche dans ce domaine s’accompagne de défis significatifs.
Ojectifs: Les objectifs visés par cet article sont triples: expliquer les obstacles auxquels se heurte généralement la recherche en santé mentale; faire ressortir les défis que posent la conception et l’application des études qui portent spécifiquement sur les troubles du comportement alimentaire; intégrer l’expérience personnelle dans la résolution des problèmes auxquels nous avons été confrontés lors d’un essai clinique aléatoire sur l’efficacité de l’olanzapine dans le traitement complémentaire d’adolescents anoerxiques.
Discussion: Nous espérons que ces résultats aideront les chercheurs à mieux comprendre les nombreux défis posés par l’étude de cette population.
Keywords: adolescents; challenges; eating disorders; obstacles; research.
Similar articles
-
Olanzapine use for the treatment of adolescents with anorexia nervosa - reflecting on research and clinical practice.J Can Acad Child Adolesc Psychiatry. 2024 Nov;33(3):164-170. Epub 2024 Nov 1. J Can Acad Child Adolesc Psychiatry. 2024. PMID: 39534775 Free PMC article.
-
Pragmatic clinical trials to advance research in children and adolescents with eating disorders.Int J Eat Disord. 2024 Jun;57(6):1350-1356. doi: 10.1002/eat.24209. Epub 2024 Apr 5. Int J Eat Disord. 2024. PMID: 38578194 Review.
-
The minority or the misunderstood? A young man's journey with anorexia nervosa.J Psychiatr Ment Health Nurs. 2021 Oct;28(5):760-772. doi: 10.1111/jpm.12784. Epub 2021 Aug 1. J Psychiatr Ment Health Nurs. 2021. PMID: 34236744
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Bulimia nervosa in adolescents: prevalence and treatment challenges.Adolesc Health Med Ther. 2018 Jan 4;9:11-16. doi: 10.2147/AHMT.S135326. eCollection 2018. Adolesc Health Med Ther. 2018. PMID: 29379324 Free PMC article. Review.
Cited by
-
The household economic burden of eating disorders and adherence to treatment in Australia.BMC Psychiatry. 2014 Nov 29;14:338. doi: 10.1186/s12888-014-0338-0. BMC Psychiatry. 2014. PMID: 25432265 Free PMC article.
-
Olanzapine use for the treatment of adolescents with anorexia nervosa - reflecting on research and clinical practice.J Can Acad Child Adolesc Psychiatry. 2024 Nov;33(3):164-170. Epub 2024 Nov 1. J Can Acad Child Adolesc Psychiatry. 2024. PMID: 39534775 Free PMC article.
-
"Include me if you can"-reasons for low enrollment of pediatric patients in a psychopharmacological trial.Trials. 2021 Mar 1;22(1):178. doi: 10.1186/s13063-021-05119-6. Trials. 2021. PMID: 33648579 Free PMC article.
References
-
- Agras WS, Brandt HA, Bulik CM, Dolan-Sewell R, Fairburn CG, Halmi KA, Herzog DB, Jimerson DC, Kaplan AS, Kaye WH, le Grange D, Lock J, Mitchell JE, Rudorfer MV, Street LL, Striegel-Moore R, Vitousek KM, Walsh BT, Wilfley DE. Report of the National Institutes of Health Workshop on Overcoming Barriers to Treatment Research in Anorexia Nervosa. International Journal of Eating Disorders. 2004;35:509–521. - PubMed
-
- Benedetto V, Jensen PS. Medication Development and Testing in Children and Adolescents: Current problems, Future Directions. Archives of General Psychiatry. 1997;54:871–876. - PubMed
-
- Berkman ND, Lohr KN, Bulik CM. Outcomes of Eating Disorders: A Systematic Review of the Literature. International Journal of Eating Disorders. 2007;40(4):293–309. - PubMed
-
- Boachie A, Goldfield GS, Spettigue W. Olanzapine Use as an Adjunctive Treatment for Hospitalized Children with Anorexia Nervosa: Case Reports. International Journal of Eating Disorders. 2003;33:98–103. - PubMed
-
- Bulik CM, Berkman ND, Brownley KA, Sedway JA, Lohr KN. Anorexia nervosa treatment: a systematic review of randomized controlled trials. International Journal of Eating Disorders. 2007;40(4):310–320. - PubMed
LinkOut - more resources
Full Text Sources